We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.16B
AUM Growth
+$312M
Cap. Flow
+$49.6M
Cap. Flow %
1.19%
Top 10 Hldgs %
18.39%
Holding
702
New
49
Increased
376
Reduced
176
Closed
46

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$26.9M
2
YHOO
Yahoo Inc
YHOO
+$20.9M
3
EMC
EMC CORPORATION
EMC
+$19.1M
4
CBRE icon
CBRE Group
CBRE
+$15.9M
5
INTC icon
Intel
INTC
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Financials 12.75%
3 Technology 11.83%
4 Communication Services 9.9%
5 Consumer Staples 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCE icon
276
BCE
BCE
$19.9B
$2.83M 0.07%
61,298
-16,446
-21% -$779K
EIX icon
277
Edison International
EIX
$30.7B
$2.82M 0.07%
39,018
-35,140
-47% -$2.64M
NEE icon
278
NextEra Energy
NEE
$187B
$2.79M 0.07%
91,336
+23,516
+35% +$741K
STML
279
DELISTED
Stemline Therapeutics, Inc.
STML
$2.78M 0.07%
+257,000
New +$2.09M
PX
280
DELISTED
Praxair Inc
PX
$2.76M 0.07%
22,874
+6,604
+41% +$782K
OMC icon
281
Omnicom Group
OMC
$22.7B
$2.75M 0.07%
32,311
+5,884
+22% +$493K
CAG icon
282
Conagra Brands
CAG
$7.07B
$2.73M 0.07%
74,615
+8,598
+13% +$309K
CST
283
DELISTED
CST Brands, Inc.
CST
$2.73M 0.07%
+56,880
New +$2.62M
VAL
284
DELISTED
Valspar
VAL
$2.73M 0.07%
25,698
+2,198
+9% +$234K
BNS icon
285
Scotiabank
BNS
$106B
$2.71M 0.07%
51,333
+4,682
+10% +$242K
RIGL icon
286
Rigel Pharmaceuticals
RIGL
$680M
$2.66M 0.06%
+72,500
New +$2.08M
CPHD
287
DELISTED
Cepheid Inc
CPHD
$2.63M 0.06%
+50,000
New +$1.99M
KPTI icon
288
Karyopharm Therapeutics
KPTI
$168M
$2.63M 0.06%
18,000
+7,333
+69% +$881K
DUK icon
289
Duke Energy
DUK
$102B
$2.62M 0.06%
32,750
+9,661
+42% +$800K
OVV icon
290
Ovintiv
OVV
$17.5B
$2.61M 0.06%
50,081
-6,246
-11% -$280K
BLK icon
291
Blackrock
BLK
$164B
$2.61M 0.06%
7,196
+2,328
+48% +$847K
RTN
292
DELISTED
Raytheon Company
RTN
$2.6M 0.06%
19,071
+2,603
+16% +$362K
FTV icon
293
Fortive
FTV
$19B
$2.54M 0.06%
+79,260
New +$2.54M
ITW icon
294
Illinois Tool Works
ITW
$81.4B
$2.52M 0.06%
21,067
+4,535
+27% +$526K
GIL icon
295
Gildan
GIL
$9.25B
$2.52M 0.06%
90,254
-43,894
-33% -$1.3M
BRCD
296
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$2.51M 0.06%
271,453
+35,972
+15% +$335K
MKC icon
297
McCormick & Company Non-Voting
MKC
$13.4B
$2.49M 0.06%
49,872
-257,254
-84% -$13M
DVA icon
298
DaVita
DVA
$15.1B
$2.49M 0.06%
37,693
+35,000
+1,300% +$2.46M
IFF icon
299
International Flavors & Fragrances
IFF
$19.4B
$2.48M 0.06%
17,360
+7,147
+70% +$968K
NOC icon
300
Northrop Grumman
NOC
$77B
$2.48M 0.06%
11,595
+1,456
+14% +$315K

Similar funds

Candriam SCA's Q3 2016 Portfolio in Review

As of Q3 2016, Candriam SCA held 702 positions worth $4.16B, up 8.1% from $3.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA's Q3 2016 filing shows 49 new, 376 increased, 176 reduced and 46 closed positions. Its largest new stake was Zions Bancorporation: 362,062 shares worth $11.2M. The largest sale was Procter & Gamble, an estimated $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Financials and Technology.

  • Candriam SCA's largest Q3 2016 buy was Zions Bancorporation: 362,062 shares worth $11.2M.
  • Candriam SCA added most to Canadian National Railway in Q3 2016, an estimated $30.2M increase.
  • Candriam SCA's biggest Q3 2016 reduction was Procter & Gamble, cutting an estimated $26.9M.
  • Candriam SCA fully exited EMC CORPORATION in Q3 2016, selling an estimated $19.1M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.16B portfolio in Q3 2016.
  • Candriam SCA opened 49 new positions and closed 46 in Q3 2016.
  • Candriam SCA's portfolio value rose 8.1% quarter-over-quarter to $4.16B.

Based on Candriam SCA's 13F filing for Q3 2016, filed 15 Nov 2016.